0001562180-19-002196.txt : 20190403
0001562180-19-002196.hdr.sgml : 20190403
20190403174403
ACCESSION NUMBER: 0001562180-19-002196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Azoy Alexander
CENTRAL INDEX KEY: 0001771961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38155
FILM NUMBER: 19730333
MAIL ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sienna Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001656328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273364627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
BUSINESS PHONE: (818) 629-2256
MAIL ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
FORMER COMPANY:
FORMER CONFORMED NAME: Sienna Labs, Inc.
DATE OF NAME CHANGE: 20151020
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-04-01
false
0001656328
Sienna Biopharmaceuticals, Inc.
SNNA
0001771961
Azoy Alexander
30699 RUSSELL RANCH ROAD
SUITE 140
WESTLAKE VILLAGE
CA
91362
false
true
false
false
Chief Financial Officer
Common Stock
2019-04-01
4
A
false
20000.00
A
37500.00
D
Stock Options (Right to buy)
2.37
2019-04-01
4
A
false
20000.00
0.00
A
2029-04-01
Common Stock
20000.00
20000.00
D
Award of restricted stock units ("RSUs") granted under the Issuer's 2017 Incentive Award Plan. Each RSU entitles the Reporting Person to receive one share of Issuer's common stock upon vesting. The award vests as to twenty-five percent (25%) of the total number of RSUs on October 1, 2019, twenty-five percent (25%) of the total number of RSUs on April 1, 2020, and the remaining fifty percent (50%) of the total number of RSUs on the second anniversary, in each case, subject to the Reporting Person's continued employment or service relationship with the Issuer through the applicable vesting date.
Includes 17,500 shares of the Issuer's common stock underlying the RSUs awarded.
Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on October 1, 2019, twenty-five percent (25%) of the shares vest and become exercisable on April 1, 2020, and the remaining shares vest and become exercisable in 12 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/Timothy K. Andrews, attorney-in-fact for Alexander Azoy
2019-04-03